Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

115 questions · 120 findings · 58 reviews

No studies found 34 · 28.3%GRADE not reported 5 · 4.2%Very low 23 · 19.2%Low 32 · 26.7%Moderate 15 · 12.5%High 11 · 9.2%

Levosimendan vs dobutamine

All‐cause long‐term mortality: range 4 to 12 months · people with cardiogenic shock or low cardiac output syndrome

Levosimendan showed no clear difference in all‐cause long‐term mortality: range 4 to 12 months compared with dobutamine (low certainty).

1 finding from 1 review